期刊文献+

丙戊酸钠对慢性粒细胞白血病细胞株K562增殖和凋亡的影响 被引量:1

Effects of Sodium Valproate on Proliferation and Apoptosis of Chronic Myeloid Leukemia Cell Line K562
下载PDF
导出
摘要 【目的】探讨丙戊酸钠(VPA)对慢性粒细胞白血病细胞株(K562细胞)增殖的影响及其可能机制。【方法】利用CCK-8法检测药物对细胞生长的影响;利用流式细胞仪检测药物处理后的细胞凋亡和细胞周期情况。【结果】VPA对K562细胞生长具有浓度-时间依赖性抑制作用;同时引起细胞凋亡增加(11.47%±0.25%),与正常对照组(4.77%±0.40%)比差异有统计学意义(P<0.05);G0/G1期细胞增多(82.30%±9.41%),S期细胞减少(12.88%±6.99%),细胞被阻滞在在G0/G1期(P<0.05)。【结论】VPA能够阻滞K562细胞于G0/G1期,最终抑制肿瘤细胞增殖并诱导其凋亡。 [Objective] To investigate the effects of sodium valproate (VPA) on the proliferation of chronic myeloid leukemia cell line K562,and to explore possible mechanisms. [ Methods ] K562 cells were treated with VPA. Cell proliferation was determined by CCK-8 assay. Cell apoptosis and cell cycle were analyzed by flow cytometry (FCM). [Results] VPA inhibited the proliferation of K562 cells in concentration- and timedependent manners. The apoptosis rate was significantly higher in the cells treated with VPA than in untreated cells[ (11.47%±0.25%)vs (4.77%±0.40%), P 〈 0.05]. After treatment of VPA, cell cycle was arrested obviously at G0/G1 phase (P 〈 0.05). [Conclusions] VPA could induce G0/G1 phase arrest, inhibit the proliferation and induce the apoptosis of K562 cells in vitro.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2008年第5期562-565,共4页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省医学科学技术基金(A2006193)
关键词 丙戊酸钠 慢性粒细胞白血病 K562细胞 增殖 凋亡 sodium valproate chronic myeloid leukemia K562 cell proliferation apoptosis
  • 相关文献

参考文献12

  • 1Takai N, Desmond JC, Kumagai T, et al. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells [J]. Clin Cancer Res, 2004,10(3):1141-1149. 被引量:1
  • 2Li XN, Shu Q, Su JM, et al. Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC [J]. Mol Cancer Ther, 2005,4(12) : 1912-1922. 被引量:1
  • 3薛红漫,李文益,郭海霞,夏焱,陈琴,刘勇.丙戊酸诱导白血病细胞凋亡机理的实验研究[J].中华儿科杂志,2005,43(12):894-898. 被引量:12
  • 4Gurvich N, Tsygankova OM, Meinkoth JL, et al. Histone deacetylase is a target of valproic acid-mediated cellular differentiation [ J ]. Cancer Res, 2004,64 ( 3 ) : 1079-1086. 被引量:1
  • 5Tony H. Treatment for chronic myelogenous leukemia: the long road to imatinib[J]. J Clin Invest, 2007,117 (8) : 2036-2043. 被引量:1
  • 6李新刚,陈燕,吴青,孙春艳.姜黄素对人淋巴瘤Raji细胞组蛋白H3乙酰化作用的影响[J].癌症,2006,25(5):582-586. 被引量:8
  • 7Minucci S, Nervi C, Lo Coco F, et al. Histone deacetylases : a common molecular target for differentiation treatment of acute myeloid leukemias? [J]. Oncogene, 2001, 20(24) : 3110-3115. 被引量:1
  • 8Weidle U H, Grossmann A. Inhibition of histone deacetylases: a new strategy to target epigenetic modifications for anticancer treatment [J]. Anticancer Res, 2000, 20(3A) : 1471-1485. 被引量:1
  • 9王重韧,黄强.脂肪酸类药物诱导分化治疗脑胶质瘤分子机制研究[J].中华神经医学杂志,2005,4(2):197-200. 被引量:3
  • 10Tang R, Faussat A M, Majdak P, et al. Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1 [J]. Leukemia, 2004,18(7) : 1246-1251. 被引量:1

二级参考文献30

  • 1李新刚,陈燕,吴青,刘红利.曲古菌素A调节NB4细胞组蛋白乙酰化和p21^(WAF1/CIP1)表达[J].华中科技大学学报(医学版),2005,34(1):41-43. 被引量:3
  • 2Xu Y,Voelter-Mahlknecht S,Mahlknecht U.The histone deacetylase inhibitor suberoylanilide hydroxamic acid down-regulates expression levels of Bcr-abl,c-Myc and HDAC3 in chronic myeloid leukemia cell lines.Int J Mol Med,2005,15:169-172. 被引量:1
  • 3Grant S.The novel histone deacetylase inhibitor NVP-LAQ824:an addition to the therapeutic armamentarium in leukemia? Leukemia,2004,18:1931-1933. 被引量:1
  • 4Romanski A,Bacic B,Bug G,et al.Use of a novel histone deacetylase inhibitor to induce apoptosis in cell lines of acute lymphoblastic leukemia.Haematologica,2004,89:419-426. 被引量:1
  • 5Gottlicher M,Minucci S,Zhu P,et al.Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells.The EMBO J,2001,24:6969-6978. 被引量:1
  • 6Tang R,Faussat AM,Majdak P,et al.Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1.Leukemia,2004,18:1246-1251. 被引量:1
  • 7Ekert PG,Silke J,Vaux DL.Caspase inhibitors.Cell Death Differ,1999,6:1081-1086. 被引量:1
  • 8Peart MJ,Tainton KM,Ruefli AA,et al.Novel Mechanisms of Apoptosis Induced by Histone Deacetylase Inhibitors.Cancer Research,2003,63:4460-4471. 被引量:1
  • 9Furukawa Y,Iwase S,Kikuchi J,et al.Phosphorylation of Bcl-2 protein by CDC2 kinase during G2-M phases and its role in cell cycle regulation.J Biol Chem,2000,275:21661-21667. 被引量:1
  • 10Borner C.Diminished cell proliferation associated with the death-protective activity of Bcl-2.J Biol Chem,1996,271:12695-12698. 被引量:1

共引文献19

同被引文献15

  • 1Li XN, Shu Q, Su JM, et al. Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expres- sion of p21Cip1 ,CDK4,and CMYC[J]. Mol Cancer Ther, 2005,4(12) : 1912-1922. 被引量:1
  • 2Bastian L, Hof J, Pfau M, et al. Synergistic activity of bortezomib and HDACi in preclinical models of B-cell pre- cursor acute lymphoblastic leukemia via modulation of p53, PI3K/AKT, and NF-κB[J]. Clin Cancer Res,2013, 19(6) :1445-1457. 被引量:1
  • 3Kostrouchova. M, Kostrouch Z, Kostrouchova M, Valproic acid, a molecular lead to multiple regulatory pathways [J]. Folia Biol (Praha), 2007,53(2) :37-49. 被引量:1
  • 4Zhang XZ, Yin AH ; Zhu XY, et al. Using an exon mi- croarray to identify a global profile of gene expression and alternative splicingin K562 cells exposed to sodium val- proate[J]. Oncol Rep,2012,27(4) : 1258-1265. 被引量:1
  • 5Zhang XZ, Yin AH, Lin D J, et al. Analyzing gene expres- sion profile in K562 cells exposed to sodium valproate u- sing microarray combined with the connectivity map data- base[ J]. J Biomed Biotechnol, 2012,2012:654291. 被引量:1
  • 6Buchi F, Pastorelli R, Ferrari G, et al. Acetylome and phosphoproteome modifications in imatinib resistant chron- ic myeloid leukaemia cells treated with valproic acid [ J ]. Leuk Res,2011,35(7) :921-931. 被引量:1
  • 7Morotti A, Cilloni D, Messa F, et al. Valproate enhances imatinib-induced growth arrest and apoptosis in chronic myeloid leukemia cells [ J ]. Cancer, 2006,106 ( 5 ) : 1188- 1106. 被引量:1
  • 8Yu C, Rahmani M, Almenara J, et al. Histone deacety- lase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr/Abl^+ human myeloid leukemia cells [ J ]. Cancer Res, 2003, 63 (9) : 2118- 2126. 被引量:1
  • 9Buchdunger E, Zimmermann J, Mett H, et al. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative [ J ]. Cancer Res, 1996, 56(1) :100-104. 被引量:1
  • 10Skorski T, BeUacosa A, Niebomwska-Skorska M, et al. Transformation of hematopoietic cells by BCR/ABL re- quires activation of a PI-3k/Akt-dependent pathway [ J ]. EMBO J,1997, 16(20) : 6151-6161. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部